Pharmacotherapeutics of SARS-CoV-2 Infections

The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neuroimmune Pharmacol
Main Authors: Kevadiya, Bhavesh D., Machhi, Jatin, Herskovitz, Jonathan, Oleynikov, Maxim D., Blomberg, Wilson R., Bajwa, Neha, Soni, Dhruvkumar, Das, Srijanee, Hasan, Mahmudul, Patel, Milankumar, Senan, Ahmed M., Gorantla, Santhi, McMillan, JoEllyn, Edagwa, Benson, Eisenberg, Robert, Gurumurthy, Channabasavaiah B., Reid, St Patrick M., Punyadeera, Chamindie, Chang, Linda, Gendelman, Howard E.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2021
Assuntos:
Invited Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785334/
https://ncbi.nlm.nih.gov/pubmed/33403500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-020-09968-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados